Skip to main content
Erschienen in: Cancer Causes & Control 2/2020

01.02.2020 | Original Paper

Immigration history, lifestyle characteristics, and breast density in the Vietnamese American Women’s Health Study: a cross-sectional analysis

verfasst von: Eunjung Lee, Namphuong Doanvo, MiHee Lee, Zayar Soe, Alice W. Lee, Cam Van Doan, Dennis Deapen, Giske Ursin, Darcy Spicer, Peggy Reynolds, Anna H. Wu

Erschienen in: Cancer Causes & Control | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Breast density is an important risk factor for breast cancer and varies substantially across racial-ethnic groups. However, determinants of breast density in Vietnamese immigrants in the United States (US) have not been studied. We investigated whether reproductive factors, immigration history, and other demographic and lifestyle factors were associated with breast density in Vietnamese Americans.

Methods

We collected information on demographics, immigration history, and other lifestyle factors and mammogram reports from a convenience sample of 380 Vietnamese American women in California aged 40 to 70 years. Breast Imaging Reporting and Data System (BI-RADS) breast density was abstracted from mammogram reports. Multivariable logistic regression was used to investigate the association between lifestyle factors and having dense breasts (BI-RADS 3 or 4).

Results

All participants were born in Viet Nam and 82% had lived in the US for 10 years or longer. Younger age, lower body mass index, nulliparity/lower number of deliveries, and longer US residence (or younger age at migration) were associated with having dense breasts. Compared to women who migrated at age 40 or later, the odds ratios and 95% confidence intervals for having dense breasts among women who migrated between the ages of 30 and 39 and before age 30 were 1.72 (0.96–3.07) and 2.48 (1.43–4.32), respectively.

Conclusions

Longer US residence and younger age at migration were associated with greater breast density in Vietnamese American women. Identifying modifiable mediating factors to reduce lifestyle changes that adversely impact breast density in this traditionally low-risk population for breast cancer is warranted.
Literatur
3.
Zurück zum Zitat Wu AH, Lee E, Stram DO (2016) Breast cancer among Asian Americans. In: Wu AH, Stram DO (eds) Cancer epidemiology among Asian Americans. Springer, Los Angeles, pp 187–218CrossRef Wu AH, Lee E, Stram DO (2016) Breast cancer among Asian Americans. In: Wu AH, Stram DO (eds) Cancer epidemiology among Asian Americans. Springer, Los Angeles, pp 187–218CrossRef
4.
Zurück zum Zitat Lee E, Liu L, Zhang J, Stern MC, Barzi A, Hwang A, Kim AE, Hamilton AS, Wu AH, Deapen D (2017) Stomach Cancer Disparity among Korean Americans by tumor characteristics: comparison with Non-Hispanic Whites, Japanese Americans, South Koreans, and Japanese. Cancer Epidemiol Biomark Prev 26(4):587–596. https://doi.org/10.1158/1055-9965.EPI-16-0573 CrossRef Lee E, Liu L, Zhang J, Stern MC, Barzi A, Hwang A, Kim AE, Hamilton AS, Wu AH, Deapen D (2017) Stomach Cancer Disparity among Korean Americans by tumor characteristics: comparison with Non-Hispanic Whites, Japanese Americans, South Koreans, and Japanese. Cancer Epidemiol Biomark Prev 26(4):587–596. https://​doi.​org/​10.​1158/​1055-9965.​EPI-16-0573 CrossRef
9.
Zurück zum Zitat Maskarinec G, Noh JJ (2004) The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis 14(3):431–439PubMed Maskarinec G, Noh JJ (2004) The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis 14(3):431–439PubMed
12.
Zurück zum Zitat Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J (2014) Cancer incidence in five continents, Vol. X. IARC Scientific Publication No. 164. International Agency for Research on Cancer, Lyon Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J (2014) Cancer incidence in five continents, Vol. X. IARC Scientific Publication No. 164. International Agency for Research on Cancer, Lyon
15.
Zurück zum Zitat McCormack VA, dos Santos SI (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 15(6):1159–1169CrossRef McCormack VA, dos Santos SI (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 15(6):1159–1169CrossRef
16.
Zurück zum Zitat Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E (1999) Effects of estrogen and estrogen-progestin on mammographic parenchymal density Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med 130(4 Pt 1):262–269CrossRef Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E (1999) Effects of estrogen and estrogen-progestin on mammographic parenchymal density Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med 130(4 Pt 1):262–269CrossRef
17.
Zurück zum Zitat McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS (2005) Estrogen-plus-progestin use and mammographic density in postmenopausal women: women's health initiative randomized trial. J Natl Cancer Inst 97(18):1366–1376. https://doi.org/10.1093/jnci/dji279 CrossRefPubMed McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS (2005) Estrogen-plus-progestin use and mammographic density in postmenopausal women: women's health initiative randomized trial. J Natl Cancer Inst 97(18):1366–1376. https://​doi.​org/​10.​1093/​jnci/​dji279 CrossRefPubMed
18.
Zurück zum Zitat Buist DS, Anderson ML, Reed SD, Aiello Bowles EJ, Fitzgibbons ED, Gandara JC, Seger D, Newton KM (2009) Short-term hormone therapy suspension and mammography recall: a randomized trial. Ann Intern Med 150(11):752–765CrossRef Buist DS, Anderson ML, Reed SD, Aiello Bowles EJ, Fitzgibbons ED, Gandara JC, Seger D, Newton KM (2009) Short-term hormone therapy suspension and mammography recall: a randomized trial. Ann Intern Med 150(11):752–765CrossRef
19.
Zurück zum Zitat Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R (2007) Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 99(5):386–395. https://doi.org/10.1093/jnci/djk066 CrossRefPubMed Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R (2007) Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 99(5):386–395. https://​doi.​org/​10.​1093/​jnci/​djk066 CrossRefPubMed
22.
Zurück zum Zitat Heng D, Gao F, Jong R, Fishell E, Yaffe M, Martin L, Li T, Stone J, Sun L, Hopper J, Boyd NF (2004) Risk factors for breast cancer associated with mammographic features in Singaporean chinese women. Cancer Epidemiol Biomark Prev 13(11 Pt 1):1751–1758 Heng D, Gao F, Jong R, Fishell E, Yaffe M, Martin L, Li T, Stone J, Sun L, Hopper J, Boyd NF (2004) Risk factors for breast cancer associated with mammographic features in Singaporean chinese women. Cancer Epidemiol Biomark Prev 13(11 Pt 1):1751–1758
26.
Zurück zum Zitat Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11(7):653–662CrossRef Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11(7):653–662CrossRef
32.
Zurück zum Zitat The Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Braaten T, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Linet MS, Ma H, Masala G, Merritt MA, Milne RL, Overvad K, Ozasa K, Palmer JR, Peeters PH, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zeleniuch-Jacquotte A, Sandler DP, Swerdlow AJ (2018) Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol 4(11):e181771. https://doi.org/10.1001/jamaoncol.2018.1771 CrossRefPubMedCentral The Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Braaten T, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Linet MS, Ma H, Masala G, Merritt MA, Milne RL, Overvad K, Ozasa K, Palmer JR, Peeters PH, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zeleniuch-Jacquotte A, Sandler DP, Swerdlow AJ (2018) Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol 4(11):e181771. https://​doi.​org/​10.​1001/​jamaoncol.​2018.​1771 CrossRefPubMedCentral
34.
Zurück zum Zitat Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, Lopez-Ridaura R, Rice M, Pereira A, Garmendia ML, Tamimi RM, Bertrand K, Kwong A, Ursin G, Lee E, Qureshi SA, Ma H, Vinnicombe S, Moss S, Allen S, Ndumia R, Vinayak S, Teo SH, Mariapun S, Fadzli F, Peplonska B, Bukowska A, Nagata C, Stone J, Hopper J, Giles G, Ozmen V, Aribal ME, Schuz J, Van Gils CH, Wanders JOP, Sirous R, Sirous M, Hipwell J, Kim J, Lee JW, Dickens C, Hartman M, Chia KS, Scott C, Chiarelli AM, Linton L, Pollan M, Flugelman AA, Salem D, Kamal R, Boyd N, Dos-Santos-Silva I, McCormack V (2017) Mammographic density and ageing: a collaborative pooled analysis of cross-sectional data from 22 countries worldwide. PLoS Med 14(6):e1002335. https://doi.org/10.1371/journal.pmed.1002335 CrossRefPubMedPubMedCentral Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, Lopez-Ridaura R, Rice M, Pereira A, Garmendia ML, Tamimi RM, Bertrand K, Kwong A, Ursin G, Lee E, Qureshi SA, Ma H, Vinnicombe S, Moss S, Allen S, Ndumia R, Vinayak S, Teo SH, Mariapun S, Fadzli F, Peplonska B, Bukowska A, Nagata C, Stone J, Hopper J, Giles G, Ozmen V, Aribal ME, Schuz J, Van Gils CH, Wanders JOP, Sirous R, Sirous M, Hipwell J, Kim J, Lee JW, Dickens C, Hartman M, Chia KS, Scott C, Chiarelli AM, Linton L, Pollan M, Flugelman AA, Salem D, Kamal R, Boyd N, Dos-Santos-Silva I, McCormack V (2017) Mammographic density and ageing: a collaborative pooled analysis of cross-sectional data from 22 countries worldwide. PLoS Med 14(6):e1002335. https://​doi.​org/​10.​1371/​journal.​pmed.​1002335 CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon C, Pike MC (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomark Prev 12:332–338 Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon C, Pike MC (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomark Prev 12:332–338
36.
Zurück zum Zitat Maskarinec G, Meng L, Ursin G (2001) Ethnic differences in mammographic densities. Int J Epidemiol 30(5):959–965CrossRef Maskarinec G, Meng L, Ursin G (2001) Ethnic differences in mammographic densities. Int J Epidemiol 30(5):959–965CrossRef
43.
Zurück zum Zitat D'Orsi CJ, Mendelson EB, Ikeda DM (2003) Breast Imaging Reporting and Data System: ACR BI-RADS-breast imaging atlas, 4th edn. American College of Radiology, Reson, VA D'Orsi CJ, Mendelson EB, Ikeda DM (2003) Breast Imaging Reporting and Data System: ACR BI-RADS-breast imaging atlas, 4th edn. American College of Radiology, Reson, VA
44.
Zurück zum Zitat D'Orsi CJ, Sickles EA, Mendelson EB, Morris EA (2013) ACR BI-RADS atlas: breast imaging re-porting and data system, 5th edn. American College of Radiology, Reston, VA, USA D'Orsi CJ, Sickles EA, Mendelson EB, Morris EA (2013) ACR BI-RADS atlas: breast imaging re-porting and data system, 5th edn. American College of Radiology, Reston, VA, USA
53.
Zurück zum Zitat Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH (2000) Mammographic parenchymal patterns and risk of breast cancer at and after a prevalence screen in Singaporean women. Int J Epidemiol 29(1):11–19CrossRef Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH (2000) Mammographic parenchymal patterns and risk of breast cancer at and after a prevalence screen in Singaporean women. Int J Epidemiol 29(1):11–19CrossRef
58.
60.
Zurück zum Zitat Heck KE, Pamuk ER (1997) Explaining the relation between education and postmenopausal breast cancer. Am J Epidemiol 145(4):366–372CrossRef Heck KE, Pamuk ER (1997) Explaining the relation between education and postmenopausal breast cancer. Am J Epidemiol 145(4):366–372CrossRef
61.
Zurück zum Zitat Heck KE, Schoendorf KC, Ventura SJ, Kiely JL (1997) Delayed childbearing by education level in the United States, 1969–1994. Matern Child Health J 1(2):81–88CrossRef Heck KE, Schoendorf KC, Ventura SJ, Kiely JL (1997) Delayed childbearing by education level in the United States, 1969–1994. Matern Child Health J 1(2):81–88CrossRef
62.
Zurück zum Zitat Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP, Yu MC (2002) Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol Biomark Prev 11(7):608–613 Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP, Yu MC (2002) Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol Biomark Prev 11(7):608–613
64.
Zurück zum Zitat Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85(22):1819–1827CrossRef Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85(22):1819–1827CrossRef
Metadaten
Titel
Immigration history, lifestyle characteristics, and breast density in the Vietnamese American Women’s Health Study: a cross-sectional analysis
verfasst von
Eunjung Lee
Namphuong Doanvo
MiHee Lee
Zayar Soe
Alice W. Lee
Cam Van Doan
Dennis Deapen
Giske Ursin
Darcy Spicer
Peggy Reynolds
Anna H. Wu
Publikationsdatum
01.02.2020
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 2/2020
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-019-01264-1

Weitere Artikel der Ausgabe 2/2020

Cancer Causes & Control 2/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.